FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in the Nordics

Biotech startups that raised Series A in the Nordics

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in the Nordics
One-time CSV
  • 43 funded companies, 32 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~nordics.csv43 rows × 18 columns
CompanyCityLast roundAmountDate
MoleculentSolnaSeries A$20.0M2026-04-30
Octarine BioCopenhagenSeries A$5.9M2026-01-22
NADMEDHelsinkiSeries A$3.9M2024-08-22
AgainCopenhagenSeries A$43.1M2024-07-17
Reshape BiotechKongens LyngbySeries A$20.0M2024-04-09
Asgard TherapeuticsLundSeries A$32.6M2024-03-14
In Singulo SolutionsStockholmSeries A$1.8M2024-02-20
Calluna PharmaOsloSeries A$81.4M2024-01-23

8 rows of the CSV in 5 of its 18 columns.

43
Startups
$567.6M
Total raised
5
Funded in the last 12 months
$217.4M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

9 of 43
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Moleculent Moleculent is a biotechnology research company. Biotech Solna, Sweden Series A $20.0M 2026-04-30 $46.0M ARCH Venture Partners, EIR Ventures 11 to 50 2021
Octarine Bio Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. Biotech Copenhagen, Denmark Series A $5.9M 2026-01-22 $15.5M MassChallenge, Vaekstfonden, Unconventional Ventures +2 11 to 50 2018
NADMED NADMED brings a new NAD metabolite measurement technology to market. Biotech Helsinki, Finland Series A $3.9M 2024-08-22 Business Finland, Voima Ventures, Nordic Science Investments 11 to 50 2022
Again Again is a carbon utilization company that converts carbon emissions into valuable chemicals. Biotech Copenhagen, Denmark Series A $43.1M 2024-07-17 Google Ventures, HV Capital, ACME Capital +1 11 to 50 2020
Reshape Biotech Reshape Biotech builds lab robots that automate routine microbiology tasks like plate filling and image analysis. Artificial intelligence Kongens Lyngby, Denmark Series A $20.0M 2024-04-09 Y Combinator, FundersClub, Astanor Ventures 11 to 50 2018
Asgard Therapeutics Asgard Therapeutics is a biotechnology company developing new therapies. Biotech Lund, Sweden Series A $32.6M 2024-03-14 $39.6M Novo Holdings, Industrifonden, Boehringer Ingelheim Venture Fund +2 11 to 50 2018
Calluna Pharma Calluna Pharma develops first-in-class therapies that target chronic inflammation and fibrosis at their source. Biotech Oslo, Norway Series A $81.4M 2024-01-23 Forbion Capital Partners, Investinor, Sarsia +1 11 to 50 2024
Hoba Therapeutics Hoba Therapeutics develops a new therapeutic protein for treating neuropathic pain. Biotech Copenhagen, Denmark Series A $24.8M 2023-12-11 European Innovation Council, EIC Accelerator, Novo Holdings +2 1 to 10 2016
Cerenion Cerenion is a medical device company that makes C-Trend, an AI-based EEG monitoring system for intensive care. Artificial intelligence Oulu, Finland Series A $3.6M 2022-04-12 Icebreaker.vc, Butterfly Ventures, Springvest 11 to 50 2017

Table 1. Biotech startups that raised Series A in the Nordics: the 9 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 43.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Moleculent Moleculent is a biotechnology research company. Biotech Solna, Sweden Series A $20.0M 2026-04-30 $46.0M ARCH Venture Partners, EIR Ventures 11 to 50 2021
2 Octarine Bio Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. Biotech Copenhagen, Denmark Series A $5.9M 2026-01-22 $15.5M MassChallenge, Vaekstfonden, Unconventional Ventures +2 11 to 50 2018

Table 2. Biotech startups that raised Series A in the Nordics: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Export and Investment Fund Government investment office Hellerup, Denmark 2 5%
2 Novo Holdings Corporate venture arm Hellerup, Denmark 2 5%
3 Springvest Private equity firm Helsinki, Finland 2 5%
4 EIR Ventures Venture capital firm Stockholm, Sweden 1 2% 1 Moleculent
5 ARCH Venture Partners Venture capital firm Chicago, United States 1 2% 1 Moleculent
6 Oskare Capital Venture capital firm Paris, France 1 2% 1 Octarine Bio
7 Unconventional Ventures Venture capital firm Copenhagen, Denmark 1 2% 1 Octarine Bio
8 The Footprint Firm Venture capital firm Copenhagen, Denmark 1 2% 1 Octarine Bio
9 MassChallenge Startup accelerator Boston, United States 1 2% 1 Octarine Bio
10 Vaekstfonden Venture capital firm Hellerup, Denmark 1 2% 1 Octarine Bio
11 Voima Ventures Venture capital firm Helsinki, Finland 1 2%
12 Nordic Science Investments Venture capital firm Helsinki, Finland 1 2%
13 Business Finland Government investment office Helsinki, Finland 1 2%
14 Google Ventures Corporate venture arm San Francisco, United States 1 2%
15 HV Capital Venture capital firm Munich, Germany 1 2%

Table 3. Biotech startups that raised Series A in the Nordics: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 36 84% $521.6M
Software 3 7% $56K
Artificial intelligence 2 5%
Hardware 1 2%

Table 4. Biotech startups that raised Series A in the Nordics by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 43 100% $11.7M

Table 5. Biotech startups that raised Series A in the Nordics by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
Denmark 22 51%
Sweden 12 28%
Finland 5 12%
Norway 3 7%
Iceland 1 2%

Table 6. Biotech startups that raised Series A in the Nordics by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Copenhagen 11 26%
Solna 3 7%
Stockholm 3 7%
Aarhus 3 7%
Helsinki 2 5%
Uppsala 2 5%
Lyngby 2 5%
Trondheim 2 5%
Hørsholm 1 2%
Gothenburg 1 2%
Kongens Lyngby 1 2%
Lund 1 2%

Table 7. Biotech startups that raised Series A in the Nordics by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 1 20% $76.7M
April 2026 1 20% $20.0M
January 2026 1 20% $5.9M
December 2025 2 40% $114.9M

Table 8. Biotech startups that raised Series A in the Nordics: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 3 7% $102.6M
2025 6 14% $177.5M
2024 11 26% $311.6M
2023 2 5% $54.8M
2022 4 9% $44.1M
2021 4 9% $75.0M

Table 9. Biotech startups that raised Series A in the Nordics by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 2 5%
2020 to 2022 8 19%
2015 to 2019 18 42%
2010 to 2014 7 16%
Before 2010 8 19%

Table 10. Biotech startups that raised Series A in the Nordics by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 15 37%
11 to 50 25 61%
51 to 100 1 2%

Table 11. Biotech startups that raised Series A in the Nordics by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in the Nordics whose last round is Series A are on the list?
43, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 43 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in the Nordics: 43 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Nordics

Other sectors that raised Series A in Nordics

Cite: FundingWatcher, 43 biotech companies in the Nordics whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/nordics/